These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8 Frey AB Cancer Immunol Res; 2017 Oct; 5(10):920-928. PubMed ID: 28874354 [TBL] [Abstract][Full Text] [Related]
5. Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis. Shitaoka K; Hamana H; Kishi H; Hayakawa Y; Kobayashi E; Sukegawa K; Piao X; Lyu F; Nagata T; Sugiyama D; Nishikawa H; Tanemura A; Katayama I; Murahashi M; Takamatsu Y; Tani K; Ozawa T; Muraguchi A Cancer Immunol Res; 2018 Apr; 6(4):378-388. PubMed ID: 29475880 [TBL] [Abstract][Full Text] [Related]
6. Multifaceted Role of BTLA in the Control of CD8 Ritthipichai K; Haymaker CL; Martinez M; Aschenbrenner A; Yi X; Zhang M; Kale C; Vence LM; Roszik J; Hailemichael Y; Overwijk WW; Varadarajan N; Nurieva R; Radvanyi LG; Hwu P; Bernatchez C Clin Cancer Res; 2017 Oct; 23(20):6151-6164. PubMed ID: 28754817 [No Abstract] [Full Text] [Related]
7. Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo. Na IK; Markley JC; Tsai JJ; Yim NL; Beattie BJ; Klose AD; Holland AM; Ghosh A; Rao UK; Stephan MT; Serganova I; Santos EB; Brentjens RJ; Blasberg RG; Sadelain M; van den Brink MR Blood; 2010 Sep; 116(11):e18-25. PubMed ID: 20511541 [TBL] [Abstract][Full Text] [Related]
8. CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction. Siriwon N; Kim YJ; Siegler E; Chen X; Rohrs JA; Liu Y; Wang P Cancer Immunol Res; 2018 Jul; 6(7):812-824. PubMed ID: 29720380 [TBL] [Abstract][Full Text] [Related]
10. Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes. Krebs S; Ahad A; Carter LM; Eyquem J; Brand C; Bell M; Ponomarev V; Reiner T; Meares CF; Gottschalk S; Sadelain M; Larson SM; Weber WA J Nucl Med; 2018 Dec; 59(12):1894-1900. PubMed ID: 29903928 [TBL] [Abstract][Full Text] [Related]
11. A Dual-Color Bioluminescence Reporter Mouse for Simultaneous Kleinovink JW; Mezzanotte L; Zambito G; Fransen MF; Cruz LJ; Verbeek JS; Chan A; Ossendorp F; Löwik C Front Immunol; 2018; 9():3097. PubMed ID: 30671062 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging. McCracken MN; Vatakis DN; Dixit D; McLaughlin J; Zack JA; Witte ON J Clin Invest; 2015 May; 125(5):1815-26. PubMed ID: 25822024 [TBL] [Abstract][Full Text] [Related]
13. Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors. Li S; Siriwon N; Zhang X; Yang S; Jin T; He F; Kim YJ; Mac J; Lu Z; Wang S; Han X; Wang P Clin Cancer Res; 2017 Nov; 23(22):6982-6992. PubMed ID: 28912137 [No Abstract] [Full Text] [Related]
15. Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy. Schlenker R; Olguín-Contreras LF; Leisegang M; Schnappinger J; Disovic A; Rühland S; Nelson PJ; Leonhardt H; Harz H; Wilde S; Schendel DJ; Uckert W; Willimsky G; Noessner E Cancer Res; 2017 Jul; 77(13):3577-3590. PubMed ID: 28533272 [TBL] [Abstract][Full Text] [Related]
16. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment. Liu YT; Tseng TC; Soong RS; Peng CY; Cheng YH; Huang SF; Chuang TH; Kao JH; Huang LR J Immunother Cancer; 2018 Dec; 6(1):144. PubMed ID: 30526672 [TBL] [Abstract][Full Text] [Related]
17. CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule. van Oers NS; Teh SJ; Garvin AM; Forbush KA; Perlmutter RM; Teh HS J Immunol; 1993 Jul; 151(2):777-90. PubMed ID: 8335907 [TBL] [Abstract][Full Text] [Related]
18. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse. Margenthaler JA; Flye MW J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA-DR transgenic mouse model of prostate cancer. Riabov V; Tretyakova I; Alexander RB; Pushko P; Klyushnenkova EN Vaccine; 2015 Oct; 33(41):5386-5395. PubMed ID: 26319744 [TBL] [Abstract][Full Text] [Related]
20. Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression. Wang Y; Sun SN; Liu Q; Yu YY; Guo J; Wang K; Xing BC; Zheng QF; Campa MJ; Patz EF; Li SY; He YW Cancer Discov; 2016 Sep; 6(9):1022-35. PubMed ID: 27297552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]